Sintx Technologies (SINT) Other Non-Current Liabilities (2013 - 2026)
Sintx Technologies (SINT) posted Other Non-Current Liabilities of $484000.0 for Q1 2026, down 41.48% on a QoQ basis from $827000.0 in Q4 2025, and up 300.0% year-over-year from $121000.0 in Q1 2025.
Powered by 
Analysis
Sintx Technologies (SINT) Other Non-Current Liabilities (2013 - 2026) Analysis & Trends
Sintx Technologies has reported Other Non-Current Liabilities for 14 years, with the latest figure at $484000.0 in Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 300.0% year-over-year to $484000.0 in Q1 2026; TTM through Mar 2026 was $484000.0, a 300.0% increase from a year earlier, with the FY2025 full-year figure at $827000.0, up 297.6% from the prior year.
- Other Non-Current Liabilities was $484000.0 for Q1 2026 at Sintx Technologies, down from $827000.0 in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $870000.0 in Q3 2025, with the low at $2000.0 in Q4 2022.
- Average Other Non-Current Liabilities over 5 years is $248812.5, with a median of $155000.0 recorded in 2023.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities tumbled 99.42% in 2022, then jumped 15100.0% in 2023.
- Over 5 years, Other Non-Current Liabilities stood at $2000.0 in 2022, then surged by 15100.0% to $304000.0 in 2023, then slumped by 31.58% to $208000.0 in 2024, then jumped by 297.6% to $827000.0 in 2025, then sank by 41.48% to $484000.0 in 2026.
- The last three Other Non-Current Liabilities figures came in at $484000.0 (Q1 2026), $827000.0 (Q4 2025), and $870000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Sintx Technologies | 8.73 Mn | 8.73 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 484,000.00 |
| Dec 31, 2025 | 827,000.00 |
| Sep 30, 2025 | 870,000.00 |
| Jun 30, 2025 | 160,000.00 |
| Mar 31, 2025 | 121,000.00 |
| Dec 31, 2024 | 208,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Dec 31, 2023 | 304,000.00 |
| Sep 30, 2023 | 72,000.00 |
| Jun 30, 2023 | 107,000.00 |
| Mar 31, 2023 | 150,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Sep 30, 2022 | 139,000.00 |
| Jun 30, 2022 | 198,000.00 |
| Mar 31, 2022 | 306,000.00 |
| Dec 31, 2021 | 347,000.00 |
| Sep 30, 2021 | 818,000.00 |
| Jun 30, 2021 | 1.30 Mn |
| Mar 31, 2021 | 1.29 Mn |